(NASDAQ: IVVD) Invivyd's forecast annual revenue growth rate of 47.33% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 31.32%, and it is also forecast to beat the US market's average forecast revenue growth rate of 14.51%.
Invivyd's revenue in 2026 is $58,365,000.On average, 5 Wall Street analysts forecast IVVD's revenue for 2026 to be $18,059,278,850, with the lowest IVVD revenue forecast at $16,551,882,623, and the highest IVVD revenue forecast at $20,179,183,751. On average, 5 Wall Street analysts forecast IVVD's revenue for 2027 to be $26,146,869,323, with the lowest IVVD revenue forecast at $20,769,290,761, and the highest IVVD revenue forecast at $31,259,165,013.
In 2028, IVVD is forecast to generate $59,178,713,434 in revenue, with the lowest revenue forecast at $37,667,220,151 and the highest revenue forecast at $87,619,984,836.